Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Frontida BioPharm Inc
FDA Inspection
•Frontida BioPharm Inc•July 17, 2015

Frontida BioPharm Inc – FDA Inspection, Jul 17, 2015

Record Details

This FDA Inspection record concerns Frontida BioPharm Inc, with an inspection on July 17, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Frontida BioPharm Inc
Inspection Date
July 17, 2015
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 2cf91318-6f6b-4647-a138-7593f304329e

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
936055
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 314.81(b)(1)(i)Mix-up
  2. 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
  3. 21 CFR 211.165(f)Failing drug products not rejected
  4. 21 CFR 211.194(a)(1)Sample identification and other information
  5. 21 CFR 211.150(b)Distribution Recall System
  6. 21 CFR 211.100(a)Absence of Written Procedures
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed
  9. 21 CFR 211.166(a)Written program not followed
  10. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Frontida BioPharm Inc

14
DateClassificationOfficeProject area
April 2, 2026Not classifiedPhiladelphia District Office
July 22, 2025NAICenter for Tobacco ProductsTobacco Post-Market Activities
July 22, 2025NAICenter for Tobacco ProductsTobacco Post-Market Activities
December 7, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 19, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 14 other inspections on the company page
Other documents for Frontida BioPharm Inc
  • FDA Inspection 1316756 - 2026-04-02
  • FDA Inspection 1280570 - 2025-07-22
  • FDA Inspection 1279864 - 2025-07-22
  • FDA Inspection 1226606 - 2023-12-07
  • FDA Inspection 1097023 - 2019-07-19

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Frontida BioPharm Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.